Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
Active site
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
===Competitive inhibitor: HIV protease inhibitor=== [[File:Indinavir, an HIV protease inhibitor.jpg|thumb|Indinavir, an HIV protease inhibitor.jpg|300px]] [[Protease inhibitor (biology)|HIV protease inhibitors]] are used to treat patients having [[AIDS]] virus by preventing its [[DNA replication]]. [[HIV-1 protease|HIV protease]] is used by the virus to cleave Gag-Pol polyprotein into 3 smaller proteins that are responsible for virion assembly, package and maturation. This enzyme targets the specific [[phenylalanine]]-[[proline]] cleave site within the target protein.<ref name="Flexner">{{cite journal|vauthors=Flexner C|date=1998|title=HIV-protease inhibitors|journal=[[The New England Journal of Medicine]]|volume=338|issue=18|pages=1281β1292|doi=10.1056/NEJM199804303381808|pmid=9562584}}</ref> If HIV protease is switched off the virion particle will lose function and cannot infect patients. Since it is essential in viral replication and is absent in healthy human, it is an ideal target for [[drug development]]. HIV protease belongs to [[aspartic protease]] family and has a similar mechanism. Firstly the [[aspartate]] residue activates a water molecule and turns it into a [[nucleophile]]. Then it attacks the [[carbonyl group]] within the [[peptide bond]] (NH-CO) to form a tetrahedral intermediate. The nitrogen atom within the intermediate receives a proton, forming an [[amide|amide group]] and subsequent rearrangement leads to the breakdown of the bond between it and the intermediate and forms two products.<ref name="Ashraf">{{cite journal|vauthors=Ashraf B, Chi-Huey W|date=2003|title=HIV-1 protease: mechanism and drug discovery|journal=[[Organic & Biomolecular Chemistry]]|volume=1|issue=1|pages=5β14|doi=10.1039/B208248A|pmid=12929379}}</ref> Inhibitors usually contain a nonhydrolyzable hydroxyethylene or hydroxyethylamine groups that mimic the tetrahedral intermediate. Since they share a similar structure and electrostatic arrangement to the [[transition state]] of substrates they can still fit into the active site but cannot be broken down, so hydrolysis cannot occur.
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)